search
Back to results

Crestor Versus Placebo in Subjects With Heart Failure

Primary Purpose

Heart Failure

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
CRESTOR
Sponsored by
AstraZeneca
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Heart Failure

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Chronic symptomatic systolic heart failure of ischaemic aetiology as judged by the investigator, optimal therapy for chronic symptomatic systolic heart failure according to the investigator Exclusion Criteria: Acute myocardial infarction within 6 months before randomization Treatment with any statin or other lipid lowering drug; or a medical condition that in the opinion of the investigator requires treatment with a statin or other lipid lowering drug

Sites / Locations

  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site

Outcomes

Primary Outcome Measures

The primary objective of this study is to determine whether rosuvastatin reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction (MI) or non-fatal stroke (time to first event).

Secondary Outcome Measures

The secondary objectives are to evaluate the effects of rosuvastatin on:
Total mortality
Any coronary event defined as the combined endpoint of sudden death or fatal or non-fatal MI or Percutaneous Transluminal Coronary Angioplasty (PTCA) or Coronary Artery Bypass Grafting (CABG) or defibrillation of ventricular fibrillation by an implant
Cardiovascular mortality with cause-specific mortality for sudden death; fatal MI; and death from worsening heart failure
Total number of hospitalizations for cardiovascular causes; for unstable angina; and for worsening heart failure

Full Information

First Posted
September 16, 2005
Last Updated
November 17, 2010
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT00206310
Brief Title
Crestor Versus Placebo in Subjects With Heart Failure
Official Title
Controlled Rosuvastatin Multinational Study in Heart Failure CORONA A Randomized, Double-Blind, Placebo Controlled Phase III Study With Rosuvastatin in Subjects With Chronic Symptomatic Systolic Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
November 2010
Overall Recruitment Status
Completed
Study Start Date
September 2003 (undefined)
Primary Completion Date
July 2007 (Actual)
Study Completion Date
July 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
AstraZeneca

4. Oversight

5. Study Description

Brief Summary
The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
5013 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
CRESTOR
Primary Outcome Measure Information:
Title
The primary objective of this study is to determine whether rosuvastatin reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction (MI) or non-fatal stroke (time to first event).
Secondary Outcome Measure Information:
Title
The secondary objectives are to evaluate the effects of rosuvastatin on:
Title
Total mortality
Title
Any coronary event defined as the combined endpoint of sudden death or fatal or non-fatal MI or Percutaneous Transluminal Coronary Angioplasty (PTCA) or Coronary Artery Bypass Grafting (CABG) or defibrillation of ventricular fibrillation by an implant
Title
Cardiovascular mortality with cause-specific mortality for sudden death; fatal MI; and death from worsening heart failure
Title
Total number of hospitalizations for cardiovascular causes; for unstable angina; and for worsening heart failure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic symptomatic systolic heart failure of ischaemic aetiology as judged by the investigator, optimal therapy for chronic symptomatic systolic heart failure according to the investigator Exclusion Criteria: Acute myocardial infarction within 6 months before randomization Treatment with any statin or other lipid lowering drug; or a medical condition that in the opinion of the investigator requires treatment with a statin or other lipid lowering drug
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
AstraZeneca Medical Science Director, MD
Organizational Affiliation
AstraZeneca
Official's Role
Study Director
Facility Information:
Facility Name
Research Site
City
Aalst
Country
Belgium
Facility Name
Research Site
City
Bouge
Country
Belgium
Facility Name
Research Site
City
Brugge
Country
Belgium
Facility Name
Research Site
City
Brussels
Country
Belgium
Facility Name
Research Site
City
Edegem
Country
Belgium
Facility Name
Research Site
City
Ensival
Country
Belgium
Facility Name
Research Site
City
Fléron
Country
Belgium
Facility Name
Research Site
City
Genk
Country
Belgium
Facility Name
Research Site
City
Huy
Country
Belgium
Facility Name
Research Site
City
Leuven
Country
Belgium
Facility Name
Research Site
City
Mol
Country
Belgium
Facility Name
Research Site
City
Turnhout
Country
Belgium
Facility Name
Research Site
City
Verviers
Country
Belgium
Facility Name
Research Site
City
Pleven
Country
Bulgaria
Facility Name
Research Site
City
Plovdiv
Country
Bulgaria
Facility Name
Research Site
City
Russe
Country
Bulgaria
Facility Name
Research Site
City
Sofia
Country
Bulgaria
Facility Name
Research Site
City
Varna
Country
Bulgaria
Facility Name
Research Site
City
Bene¿ov u Prahy
Country
Czech Republic
Facility Name
Research Site
City
Bene¿ov
Country
Czech Republic
Facility Name
Research Site
City
Brno
Country
Czech Republic
Facility Name
Research Site
City
Hradec Králové 5
Country
Czech Republic
Facility Name
Research Site
City
Hradec Králové
Country
Czech Republic
Facility Name
Research Site
City
Jihlava
Country
Czech Republic
Facility Name
Research Site
City
Kladno
Country
Czech Republic
Facility Name
Research Site
City
Liberec
Country
Czech Republic
Facility Name
Research Site
City
Ostrava 1
Country
Czech Republic
Facility Name
Research Site
City
Ostrava 3 - Vítkovice
Country
Czech Republic
Facility Name
Research Site
City
Ostrava
Country
Czech Republic
Facility Name
Research Site
City
Pelh¿imov
Country
Czech Republic
Facility Name
Research Site
City
Plze¿-Bory
Country
Czech Republic
Facility Name
Research Site
City
Plze¿
Country
Czech Republic
Facility Name
Research Site
City
Praha 10
Country
Czech Republic
Facility Name
Research Site
City
Praha 1
Country
Czech Republic
Facility Name
Research Site
City
Praha 2
Country
Czech Republic
Facility Name
Research Site
City
Praha 5
Country
Czech Republic
Facility Name
Research Site
City
Praha 6
Country
Czech Republic
Facility Name
Research Site
City
P¿íbram V - Zdabo¿
Country
Czech Republic
Facility Name
Research Site
City
P¿íbram
Country
Czech Republic
Facility Name
Research Site
City
Slaný
Country
Czech Republic
Facility Name
Research Site
City
Tábor
Country
Czech Republic
Facility Name
Research Site
City
¿eská Lípa
Country
Czech Republic
Facility Name
Research Site
City
¿eské Bud¿jovice
Country
Czech Republic
Facility Name
Research Site
City
Ústí nad Labem
Country
Czech Republic
Facility Name
Research Site
City
Aalborg
Country
Denmark
Facility Name
Research Site
City
Esbjerg
Country
Denmark
Facility Name
Research Site
City
Frederiksberg
Country
Denmark
Facility Name
Research Site
City
Frederikssund
Country
Denmark
Facility Name
Research Site
City
Glostrup
Country
Denmark
Facility Name
Research Site
City
Haderslev
Country
Denmark
Facility Name
Research Site
City
Helsingør
Country
Denmark
Facility Name
Research Site
City
Horsens
Country
Denmark
Facility Name
Research Site
City
Hvidovre
Country
Denmark
Facility Name
Research Site
City
Kbh. S
Country
Denmark
Facility Name
Research Site
City
Kolding
Country
Denmark
Facility Name
Research Site
City
København N
Country
Denmark
Facility Name
Research Site
City
København Ø
Country
Denmark
Facility Name
Research Site
City
København
Country
Denmark
Facility Name
Research Site
City
Næstved
Country
Denmark
Facility Name
Research Site
City
Odense C
Country
Denmark
Facility Name
Research Site
City
Roskilde
Country
Denmark
Facility Name
Research Site
City
Svendborg
Country
Denmark
Facility Name
Research Site
City
Viborg
Country
Denmark
Facility Name
Research Site
City
Helsinki
Country
Finland
Facility Name
Research Site
City
Hyvinkää
Country
Finland
Facility Name
Research Site
City
Kemi
Country
Finland
Facility Name
Research Site
City
Kokkola
Country
Finland
Facility Name
Research Site
City
Lahti
Country
Finland
Facility Name
Research Site
City
Lappeenranta
Country
Finland
Facility Name
Research Site
City
Mariehamn
Country
Finland
Facility Name
Research Site
City
Oulu
Country
Finland
Facility Name
Research Site
City
Pietarsaari
Country
Finland
Facility Name
Research Site
City
Porvoo
Country
Finland
Facility Name
Research Site
City
Seinäjoki
Country
Finland
Facility Name
Research Site
City
Tampere
Country
Finland
Facility Name
Research Site
City
Uusikaupunki
Country
Finland
Facility Name
Research Site
City
Allauch
Country
France
Facility Name
Research Site
City
Antony
Country
France
Facility Name
Research Site
City
Arras
Country
France
Facility Name
Research Site
City
Cambrai Cedex
Country
France
Facility Name
Research Site
City
Cergy Pontoise
Country
France
Facility Name
Research Site
City
Chambray Les Tours
Country
France
Facility Name
Research Site
City
Chantepie
Country
France
Facility Name
Research Site
City
CHOLET Cedex
Country
France
Facility Name
Research Site
City
Croix
Country
France
Facility Name
Research Site
City
Dechy
Country
France
Facility Name
Research Site
City
Gonesse
Country
France
Facility Name
Research Site
City
Grenoble Cedex 9
Country
France
Facility Name
Research Site
City
Le Coudray
Country
France
Facility Name
Research Site
City
Lille
Country
France
Facility Name
Research Site
City
Montfermeil
Country
France
Facility Name
Research Site
City
Nantes Cedex 2
Country
France
Facility Name
Research Site
City
Paris
Country
France
Facility Name
Research Site
City
Pessac
Country
France
Facility Name
Research Site
City
Rennes
Country
France
Facility Name
Research Site
City
Roubaix
Country
France
Facility Name
Research Site
City
SAINT DENIS Cedex
Country
France
Facility Name
Research Site
City
Saint Herblain
Country
France
Facility Name
Research Site
City
Salouel
Country
France
Facility Name
Research Site
City
Senlis
Country
France
Facility Name
Research Site
City
Six Fours Les Plages
Country
France
Facility Name
Research Site
City
Toulouse
Country
France
Facility Name
Research Site
City
Tourcoing
Country
France
Facility Name
Research Site
City
Valenciennes
Country
France
Facility Name
Research Site
City
Stuttgart
State/Province
Baden-Württemberg
Country
Germany
Facility Name
Research Site
City
München
State/Province
Bayern
Country
Germany
Facility Name
Research Site
City
Regensburg
State/Province
Bayern
Country
Germany
Facility Name
Research Site
City
Cottbus
State/Province
Brandenburg
Country
Germany
Facility Name
Research Site
City
Frankfurt
State/Province
Hessen
Country
Germany
Facility Name
Research Site
City
Greifswald
State/Province
Mecklenburg-Vorpommern
Country
Germany
Facility Name
Research Site
City
Göttingen
State/Province
Niedersachsen
Country
Germany
Facility Name
Research Site
City
Hannover
State/Province
Niedersachsen
Country
Germany
Facility Name
Research Site
City
Düsseldorf
State/Province
Nordrhein-Westfalen
Country
Germany
Facility Name
Research Site
City
Saarbrücken
State/Province
Saarland
Country
Germany
Facility Name
Research Site
City
Halle
State/Province
Sachsen-Anhalt
Country
Germany
Facility Name
Research Site
City
Dresden
State/Province
Sachsen
Country
Germany
Facility Name
Research Site
City
Leipzig
State/Province
Sachsen
Country
Germany
Facility Name
Research Site
City
Bad Segeberg
State/Province
Schleswig-Holstein
Country
Germany
Facility Name
Research Site
City
Lübeck
State/Province
Schleswig-Holstein
Country
Germany
Facility Name
Research Site
City
Jena-Maua
State/Province
Thüringen
Country
Germany
Facility Name
Research Site
City
Aachen
Country
Germany
Facility Name
Research Site
City
Bad Nauheim
Country
Germany
Facility Name
Research Site
City
Bad Neustadt
Country
Germany
Facility Name
Research Site
City
Bad Wörishofen
Country
Germany
Facility Name
Research Site
City
Berlin
Country
Germany
Facility Name
Research Site
City
Brandenburg
Country
Germany
Facility Name
Research Site
City
Braunschweig
Country
Germany
Facility Name
Research Site
City
Coburg
Country
Germany
Facility Name
Research Site
City
Cottbus
Country
Germany
Facility Name
Research Site
City
Dillingen
Country
Germany
Facility Name
Research Site
City
Dresden
Country
Germany
Facility Name
Research Site
City
Erfurt
Country
Germany
Facility Name
Research Site
City
Essen
Country
Germany
Facility Name
Research Site
City
Esslingen
Country
Germany
Facility Name
Research Site
City
Greifswald
Country
Germany
Facility Name
Research Site
City
Görlitz
Country
Germany
Facility Name
Research Site
City
Göttingen
Country
Germany
Facility Name
Research Site
City
Halle
Country
Germany
Facility Name
Research Site
City
Hamburg
Country
Germany
Facility Name
Research Site
City
Kassel
Country
Germany
Facility Name
Research Site
City
Leipzig
Country
Germany
Facility Name
Research Site
City
Leisnig
Country
Germany
Facility Name
Research Site
City
Löbau
Country
Germany
Facility Name
Research Site
City
Lübeck
Country
Germany
Facility Name
Research Site
City
Mannheim
Country
Germany
Facility Name
Research Site
City
München
Country
Germany
Facility Name
Research Site
City
Neustadt/Aisch
Country
Germany
Facility Name
Research Site
City
Norderstedt
Country
Germany
Facility Name
Research Site
City
Nordhorn
Country
Germany
Facility Name
Research Site
City
Regensburg
Country
Germany
Facility Name
Research Site
City
Riesa
Country
Germany
Facility Name
Research Site
City
Rüdersdorf
Country
Germany
Facility Name
Research Site
City
Timmendorfer Strand
Country
Germany
Facility Name
Research Site
City
Tübingen
Country
Germany
Facility Name
Research Site
City
Vechta
Country
Germany
Facility Name
Research Site
City
Wedel
Country
Germany
Facility Name
Research Site
City
Wermsdorf
Country
Germany
Facility Name
Research Site
City
Wolmirstedt
Country
Germany
Facility Name
Research Site
City
Balatonfüred
Country
Hungary
Facility Name
Research Site
City
Budapest
Country
Hungary
Facility Name
Research Site
City
Cegléd
Country
Hungary
Facility Name
Research Site
City
Debrecen
Country
Hungary
Facility Name
Research Site
City
Eger
Country
Hungary
Facility Name
Research Site
City
Gyula
Country
Hungary
Facility Name
Research Site
City
Kecskemét
Country
Hungary
Facility Name
Research Site
City
Mosonmagyaróvár
Country
Hungary
Facility Name
Research Site
City
Sopron
Country
Hungary
Facility Name
Research Site
City
Szentes
Country
Hungary
Facility Name
Research Site
City
Szolnok
Country
Hungary
Facility Name
Research Site
City
Székesfehérvár
Country
Hungary
Facility Name
Research Site
City
Ballinasloe
State/Province
Co. Galway
Country
Ireland
Facility Name
Research Site
City
Dublin 8
Country
Ireland
Facility Name
Research Site
City
Ryhope, SUNDERLAND
Country
Ireland
Facility Name
Research Site
City
Alkmaar
Country
Netherlands
Facility Name
Research Site
City
Almelo
Country
Netherlands
Facility Name
Research Site
City
Amersfoort
Country
Netherlands
Facility Name
Research Site
City
Amsterdam
Country
Netherlands
Facility Name
Research Site
City
Apeldoorn
Country
Netherlands
Facility Name
Research Site
City
Blaricum
Country
Netherlands
Facility Name
Research Site
City
Breda
Country
Netherlands
Facility Name
Research Site
City
Capelle Aan Den Ijssel
Country
Netherlands
Facility Name
Research Site
City
Delft
Country
Netherlands
Facility Name
Research Site
City
Den Bosch
Country
Netherlands
Facility Name
Research Site
City
Den Haag
Country
Netherlands
Facility Name
Research Site
City
Den Helder
Country
Netherlands
Facility Name
Research Site
City
Deventer
Country
Netherlands
Facility Name
Research Site
City
Dirksland
Country
Netherlands
Facility Name
Research Site
City
Dordrecht
Country
Netherlands
Facility Name
Research Site
City
EDE
Country
Netherlands
Facility Name
Research Site
City
Enschede
Country
Netherlands
Facility Name
Research Site
City
Goes
Country
Netherlands
Facility Name
Research Site
City
Gorinchem
Country
Netherlands
Facility Name
Research Site
City
Gouda
Country
Netherlands
Facility Name
Research Site
City
Groningen
Country
Netherlands
Facility Name
Research Site
City
Haarlem
Country
Netherlands
Facility Name
Research Site
City
Hardenberg
Country
Netherlands
Facility Name
Research Site
City
Heerenveen
Country
Netherlands
Facility Name
Research Site
City
Heerlen
Country
Netherlands
Facility Name
Research Site
City
Helmond
Country
Netherlands
Facility Name
Research Site
City
Hengelo
Country
Netherlands
Facility Name
Research Site
City
Hilversum
Country
Netherlands
Facility Name
Research Site
City
Hoofddorp
Country
Netherlands
Facility Name
Research Site
City
Leiden
Country
Netherlands
Facility Name
Research Site
City
Lelystad
Country
Netherlands
Facility Name
Research Site
City
Maastricht
Country
Netherlands
Facility Name
Research Site
City
Nijmegen
Country
Netherlands
Facility Name
Research Site
City
OSS
Country
Netherlands
Facility Name
Research Site
City
Roermond
Country
Netherlands
Facility Name
Research Site
City
Roosendaal
Country
Netherlands
Facility Name
Research Site
City
Rotterdam
Country
Netherlands
Facility Name
Research Site
City
Schiedam
Country
Netherlands
Facility Name
Research Site
City
Sittard
Country
Netherlands
Facility Name
Research Site
City
Sneek
Country
Netherlands
Facility Name
Research Site
City
Tiel
Country
Netherlands
Facility Name
Research Site
City
Tilburg
Country
Netherlands
Facility Name
Research Site
City
Veldhoven
Country
Netherlands
Facility Name
Research Site
City
Velp
Country
Netherlands
Facility Name
Research Site
City
Venlo
Country
Netherlands
Facility Name
Research Site
City
Zeist
Country
Netherlands
Facility Name
Research Site
City
Zoetermeer
Country
Netherlands
Facility Name
Research Site
City
Zwolle
Country
Netherlands
Facility Name
Research Site
City
Arendal
Country
Norway
Facility Name
Research Site
City
Drammen
Country
Norway
Facility Name
Research Site
City
Flekkefjord
Country
Norway
Facility Name
Research Site
City
Fredrikstad
Country
Norway
Facility Name
Research Site
City
Førde
Country
Norway
Facility Name
Research Site
City
Gjettum
Country
Norway
Facility Name
Research Site
City
Gjøvik
Country
Norway
Facility Name
Research Site
City
Hamar
Country
Norway
Facility Name
Research Site
City
Lillehammer
Country
Norway
Facility Name
Research Site
City
Oslo
Country
Norway
Facility Name
Research Site
City
Porsgrunn
Country
Norway
Facility Name
Research Site
City
Tromsø
Country
Norway
Facility Name
Research Site
City
Bialystok
Country
Poland
Facility Name
Research Site
City
Bia¿ystok
Country
Poland
Facility Name
Research Site
City
Bydgoszcz
Country
Poland
Facility Name
Research Site
City
Chojnice
Country
Poland
Facility Name
Research Site
City
Gdansk
Country
Poland
Facility Name
Research Site
City
Gdynia
Country
Poland
Facility Name
Research Site
City
Gliwice
Country
Poland
Facility Name
Research Site
City
Inowroc¿aw
Country
Poland
Facility Name
Research Site
City
I¿awa
Country
Poland
Facility Name
Research Site
City
Katowice
Country
Poland
Facility Name
Research Site
City
Kielce
Country
Poland
Facility Name
Research Site
City
Lodz
Country
Poland
Facility Name
Research Site
City
Lublin
Country
Poland
Facility Name
Research Site
City
Olsztyn
Country
Poland
Facility Name
Research Site
City
Ostrowiec ¿wi¿tokrzyski
Country
Poland
Facility Name
Research Site
City
O¿awa
Country
Poland
Facility Name
Research Site
City
Piotrków Trybunalski
Country
Poland
Facility Name
Research Site
City
Poznan
Country
Poland
Facility Name
Research Site
City
Ruda ¿l¿ska
Country
Poland
Facility Name
Research Site
City
Siedlce
Country
Poland
Facility Name
Research Site
City
Skierniewice
Country
Poland
Facility Name
Research Site
City
Warszawa
Country
Poland
Facility Name
Research Site
City
Wroclaw
Country
Poland
Facility Name
Research Site
City
Zabrze
Country
Poland
Facility Name
Research Site
City
Zamo¿¿
Country
Poland
Facility Name
Research Site
City
¿yrardów
Country
Poland
Facility Name
Research Site
City
¿ód¿
Country
Poland
Facility Name
Research Site
City
Almada
Country
Portugal
Facility Name
Research Site
City
Amadora
Country
Portugal
Facility Name
Research Site
City
Barreiro
Country
Portugal
Facility Name
Research Site
City
Carnaxide
Country
Portugal
Facility Name
Research Site
City
Coimbra
Country
Portugal
Facility Name
Research Site
City
Funchal
Country
Portugal
Facility Name
Research Site
City
Lisboa
Country
Portugal
Facility Name
Research Site
City
Penafiel
Country
Portugal
Facility Name
Research Site
City
Porto
Country
Portugal
Facility Name
Research Site
City
Vila Franca de Xira
Country
Portugal
Facility Name
Research Site
City
Brasov
Country
Romania
Facility Name
Research Site
City
Bucharest
Country
Romania
Facility Name
Research Site
City
Cluj-Napoca
Country
Romania
Facility Name
Research Site
City
Craiova
Country
Romania
Facility Name
Research Site
City
Targu-Mures
Country
Romania
Facility Name
Research Site
City
Moscow
State/Province
Russia
Country
Russian Federation
Facility Name
Research Site
City
Bardejov
Country
Slovakia
Facility Name
Research Site
City
Bratislava
Country
Slovakia
Facility Name
Research Site
City
Dolný Kubín
Country
Slovakia
Facility Name
Research Site
City
Ko¿ice
Country
Slovakia
Facility Name
Research Site
City
Lu¿enec
Country
Slovakia
Facility Name
Research Site
City
Nitra
Country
Slovakia
Facility Name
Research Site
City
Nové Zámky
Country
Slovakia
Facility Name
Research Site
City
Pre¿ov
Country
Slovakia
Facility Name
Research Site
City
Rimavská Sobota
Country
Slovakia
Facility Name
Research Site
City
Bloemfontein
State/Province
Free State
Country
South Africa
Facility Name
Research Site
City
Soweto
State/Province
Gauteng
Country
South Africa
Facility Name
Research Site
City
Durban
State/Province
KwaZulu Natal
Country
South Africa
Facility Name
Research Site
City
Somerset West
State/Province
Western Cape
Country
South Africa
Facility Name
Research Site
City
Bloemfontein
Country
South Africa
Facility Name
Research Site
City
Cape Town
Country
South Africa
Facility Name
Research Site
City
Lyttelton Manor
Country
South Africa
Facility Name
Research Site
City
Parktown
Country
South Africa
Facility Name
Research Site
City
Tygerberg
Country
South Africa
Facility Name
Research Site
City
Santiago de Compostela
State/Province
A Coruña
Country
Spain
Facility Name
Research Site
City
Santiago
State/Province
A Coruña
Country
Spain
Facility Name
Research Site
City
San Juan
State/Province
Alicante
Country
Spain
Facility Name
Research Site
City
Badalona
State/Province
Barcelona
Country
Spain
Facility Name
Research Site
City
Terrassa
State/Province
Barcelona
Country
Spain
Facility Name
Research Site
City
A Coruña
State/Province
Galicia
Country
Spain
Facility Name
Research Site
City
San Sebastián
State/Province
Guipuzcoa
Country
Spain
Facility Name
Research Site
City
Alcorcón
State/Province
Madrid
Country
Spain
Facility Name
Research Site
City
Marbella
State/Province
Málaga
Country
Spain
Facility Name
Research Site
City
Vigo
State/Province
Pontevedra
Country
Spain
Facility Name
Research Site
City
Barcelona
Country
Spain
Facility Name
Research Site
City
Castellón
Country
Spain
Facility Name
Research Site
City
Madrid
Country
Spain
Facility Name
Research Site
City
Málaga
Country
Spain
Facility Name
Research Site
City
Palma de Mallorca
Country
Spain
Facility Name
Research Site
City
Salamanca
Country
Spain
Facility Name
Research Site
City
Santander
Country
Spain
Facility Name
Research Site
City
Sevilla
Country
Spain
Facility Name
Research Site
City
Danderyd
Country
Sweden
Facility Name
Research Site
City
Eksjö
Country
Sweden
Facility Name
Research Site
City
Enköping
Country
Sweden
Facility Name
Research Site
City
Göteborg
Country
Sweden
Facility Name
Research Site
City
Hudiksvall
Country
Sweden
Facility Name
Research Site
City
Jönköping
Country
Sweden
Facility Name
Research Site
City
Karlstad
Country
Sweden
Facility Name
Research Site
City
Linköping
Country
Sweden
Facility Name
Research Site
City
Lund
Country
Sweden
Facility Name
Research Site
City
Motala
Country
Sweden
Facility Name
Research Site
City
Mölndal
Country
Sweden
Facility Name
Research Site
City
Oskarshamn
Country
Sweden
Facility Name
Research Site
City
Stockholm
Country
Sweden
Facility Name
Research Site
City
Uppsala
Country
Sweden
Facility Name
Research Site
City
Västervik
Country
Sweden
Facility Name
Research Site
City
Ängelholm
Country
Sweden
Facility Name
Research Site
City
Bellinzona
Country
Switzerland
Facility Name
Research Site
City
Bern
Country
Switzerland
Facility Name
Research Site
City
Genève 14
Country
Switzerland
Facility Name
Research Site
City
Lugano
Country
Switzerland
Facility Name
Research Site
City
Schlieren
Country
Switzerland
Facility Name
Research Site
City
Zürich
Country
Switzerland
Facility Name
Research Site
City
Cottingham
State/Province
Hull
Country
United Kingdom
Facility Name
Research Site
City
Sidcup
State/Province
Kent
Country
United Kingdom
Facility Name
Research Site
City
Airdrie
State/Province
Lanarkshire
Country
United Kingdom
Facility Name
Research Site
City
Essex
State/Province
London
Country
United Kingdom
Facility Name
Research Site
City
Antrim
State/Province
Northern Ireland
Country
United Kingdom
Facility Name
Research Site
City
Belfast
State/Province
Northern Ireland
Country
United Kingdom
Facility Name
Research Site
City
Paisley
State/Province
Renfrewhsire
Country
United Kingdom
Facility Name
Research Site
City
Bridgend
State/Province
Wales
Country
United Kingdom
Facility Name
Research Site
City
Aberdeen
Country
United Kingdom
Facility Name
Research Site
City
Ayr
Country
United Kingdom
Facility Name
Research Site
City
Basingstoke
Country
United Kingdom
Facility Name
Research Site
City
Belfast
Country
United Kingdom
Facility Name
Research Site
City
Blackpool
Country
United Kingdom
Facility Name
Research Site
City
Bridgend
Country
United Kingdom
Facility Name
Research Site
City
Brighton
Country
United Kingdom
Facility Name
Research Site
City
Bristol
Country
United Kingdom
Facility Name
Research Site
City
Carshalton
Country
United Kingdom
Facility Name
Research Site
City
Croyden
Country
United Kingdom
Facility Name
Research Site
City
Croydon
Country
United Kingdom
Facility Name
Research Site
City
Durham
Country
United Kingdom
Facility Name
Research Site
City
East Kilbride
Country
United Kingdom
Facility Name
Research Site
City
Edinburgh
Country
United Kingdom
Facility Name
Research Site
City
Essex
Country
United Kingdom
Facility Name
Research Site
City
Glasgow
Country
United Kingdom
Facility Name
Research Site
City
Hastings
Country
United Kingdom
Facility Name
Research Site
City
High Wycombe
Country
United Kingdom
Facility Name
Research Site
City
Hull
Country
United Kingdom
Facility Name
Research Site
City
Kent
Country
United Kingdom
Facility Name
Research Site
City
Kirkcaldy
Country
United Kingdom
Facility Name
Research Site
City
Leicester
Country
United Kingdom
Facility Name
Research Site
City
Liverpool
Country
United Kingdom
Facility Name
Research Site
City
Llantrisant
Country
United Kingdom
Facility Name
Research Site
City
London
Country
United Kingdom
Facility Name
Research Site
City
Middlesex
Country
United Kingdom
Facility Name
Research Site
City
Newport
Country
United Kingdom
Facility Name
Research Site
City
Northumberland
Country
United Kingdom
Facility Name
Research Site
City
Paisley
Country
United Kingdom
Facility Name
Research Site
City
Poole
Country
United Kingdom
Facility Name
Research Site
City
Ryhope, SUNDERLAND
Country
United Kingdom
Facility Name
Research Site
City
Scunthorpe
Country
United Kingdom
Facility Name
Research Site
City
Sheffield
Country
United Kingdom
Facility Name
Research Site
City
Sunderland
Country
United Kingdom
Facility Name
Research Site
City
West Bromwich
Country
United Kingdom
Facility Name
Research Site
City
York
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
26288364
Citation
Askevold ET, Gullestad L, Nymo S, Kjekshus J, Yndestad A, Latini R, Cleland JG, McMurray JJ, Aukrust P, Ueland T. Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). PLoS One. 2015 Aug 19;10(8):e0133970. doi: 10.1371/journal.pone.0133970. eCollection 2015.
Results Reference
derived
PubMed Identifier
24622117
Citation
Perez AC, Jhund PS, Stott DJ, Gullestad L, Cleland JG, van Veldhuisen DJ, Wikstrand J, Kjekshus J, McMurray JJ. Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure). JACC Heart Fail. 2014 Feb;2(1):35-40. doi: 10.1016/j.jchf.2013.07.008. Epub 2014 Jan 25.
Results Reference
derived
PubMed Identifier
24284025
Citation
Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail. 2014 Jan;7(1):96-103. doi: 10.1161/CIRCHEARTFAILURE.113.000450. Epub 2013 Nov 27.
Results Reference
derived
PubMed Identifier
23473415
Citation
Perez AC, Jhund P, Preiss D, Kjekshus J, McMurray JJ. Effect of rosuvastatin on fatigue in patients with heart failure. J Am Coll Cardiol. 2013 Mar 12;61(10):1121-2. doi: 10.1016/j.jacc.2012.12.004. No abstract available.
Results Reference
derived
PubMed Identifier
23395934
Citation
van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail. 2013 Mar;6(2):219-26. doi: 10.1161/CIRCHEARTFAILURE.112.000129. Epub 2013 Feb 8.
Results Reference
derived
PubMed Identifier
23230311
Citation
Askevold ET, Nymo S, Ueland T, Gravning J, Wergeland R, Kjekshus J, Yndestad A, Cleland JG, McMurray JJ, Aukrust P, Gullestad L. Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Circ Heart Fail. 2013 Jan;6(1):91-8. doi: 10.1161/CIRCHEARTFAILURE.112.972653. Epub 2012 Dec 10.
Results Reference
derived
PubMed Identifier
23194488
Citation
Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Aukrust P. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Am Heart J. 2012 Dec;164(6):878-83. doi: 10.1016/j.ahj.2012.08.021. Epub 2012 Oct 29.
Results Reference
derived
PubMed Identifier
22740508
Citation
Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vardal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. Eur J Heart Fail. 2012 Sep;14(9):992-9. doi: 10.1093/eurjhf/hfs092. Epub 2012 Jun 27.
Results Reference
derived
PubMed Identifier
22304793
Citation
Stein EA, Vidt DG, Shepherd J, Cain VA, Anzalone D, Cressman MD. Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program. Atherosclerosis. 2012 Apr;221(2):471-7. doi: 10.1016/j.atherosclerosis.2011.12.011. Epub 2012 Jan 3.
Results Reference
derived
PubMed Identifier
21216833
Citation
Ueland T, Dahl CP, Kjekshus J, Hulthe J, Bohm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332. Epub 2011 Jan 7.
Results Reference
derived
PubMed Identifier
20883926
Citation
McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Bohm M, Kamensky G, Komajda M, Mareev V, Wikstrand J; CORONA Study Group. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010 Oct 5;56(15):1196-204. doi: 10.1016/j.jacc.2010.02.075.
Results Reference
derived
PubMed Identifier
20501489
Citation
Inglis SC, McMurray JJ, Bohm M, Schaufelberger M, van Veldhuisen DJ, Lindberg M, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Eur J Heart Fail. 2010 Jul;12(7):698-705. doi: 10.1093/eurjhf/hfq070. Epub 2010 May 25.
Results Reference
derived
PubMed Identifier
19917888
Citation
McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamensky G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J; CORONA Study Group. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis. Circulation. 2009 Dec 1;120(22):2188-96. doi: 10.1161/CIRCULATIONAHA.109.849117. Epub 2009 Nov 16. Erratum In: Circulation. 2010 Jun 29;121(25):e461.
Results Reference
derived
PubMed Identifier
17984166
Citation
Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007 Nov 29;357(22):2248-61. doi: 10.1056/NEJMoa0706201. Epub 2007 Nov 5.
Results Reference
derived

Learn more about this trial

Crestor Versus Placebo in Subjects With Heart Failure

We'll reach out to this number within 24 hrs